search img
On-Body Delivery System - Stevanato Group
Home - Stevanato Group > Offering - Stevanato Group > ドラッグ・デリバリー・システム - Stevanato Group > 独自のライセンスデバイス - Stevanato Group > On-Body Delivery System - Stevanato Group
page-wrapper

A readily customizable on-body solution for the drug delivery market

Stevanato Group’s On-Body Delivery System (OBDS) is a semi-reusable drug delivery device composed of a disposable pod with a pre-loaded cartridge and a reusable controller. With the ability to deliver micro-precision basal doses and full-content bolus injections, the OBDS is a highly flexible, customizable platform suitable for a wide range of therapies.

OBDS_infographic_open
OBDS_infographic_open

User interface

The On-Body Delivery System is a flexible platform that can readily accommodate customizations in the user interface, including buttons, visual indications and icons.

OBDS_infographic_interactive_DK
OBDS_infographic_interactive_MB

Therapeutic areas

348_Water_diluent

Suitable for a broad range of subcutaneous Therapeutic Areas; especially applicable for complex regimens, including small molecules and large molecules (MABs).

174D Wearable Vertiva

Platform adaptable for Oncology, Central Nervous System, Psychiatric disorders, Pain Management and more

Therapeutic areas

Features

89 Filled Cartridge
Standard 3mL pre-filled cartridge, pre-loaded in Pod during final assembly
174F Wearable Vertiva Locked
Watertight enclosure, with no patient access to medication container
75 Customization
Fully programmable delivery, from micro-precision basal doses to full-content boluses
193B Problem To Solve
Simple user interface with audible, visual and tactile feedback
12 Environment
Semi-reusable system reducing environmental impact of electronic components

統合機能

274_design circle
デバイス設計
89_Cartridge filled circle
ガラス容器の設計と製造。SG EZ-fillも利用可能
66_analytical circle
ガラス容器の分析・試験サービスおよびデバイスの各種機能試験
196A_Molding circle
プラスチック射出成形、流路のサブアセンブリ
267_SVMarm circle
最終組立・梱包
SG_EZ-be Pod_Bexson_draw
SG_EZ-be Pod_Bexson_draw

On-Body Device ketamine formulation  developed in collaboration with Bexson Biomedical, Inc. to treat chronic and acute pain disorders

READ PRESS RELEASE

Interested in On-Body Delivery System?
Submit your request